Peak HumanDatabase
    All Research
    PAPER GFAP-OCohort Study

    Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study

    In more than 1,000 adults aged 79-94 without dementia (AgeCoDe), plasma GFAP — with p-tau and NfL — was associated with progression to Alzheimer-type dementia and cognitive decline.

    Evidence

    6/10

    Moderate Evidence

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    —

    02

    Key Findings

    1. 01

      Plasma GFAP associated with progression to AD dementia in the oldest-old

    03

    Structured Methods

    Study Design
    Cohort Study
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (n.d.). Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study.

    Source

    Publisher

    05

    Indexing

    Topics

    Alzheimer'sprognosis

    Biomarkers

    GFAPNfLp-Tau 181
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation
    See your Peak Human Score How it works